New generations of dihydropyridines for treatment of hypertension
Angela L Wang
Costantino Iadecola
Gang Wang
摘要：Since the calcium channel blocker (CCB) has become one of the most prescribed agents for antihypertensive monotherapy in the world,this brief review will focus on the recent research and development of the dihydropyridine (DHP) CCB,addressing pharmacological mechanisms for the clinical efficacy of the third and fourth generations of the DHP CCBs,especially on their possible central mechanisms underlying lowering blood pressure.
机标关键词：
论文发表日期：2017-01-01
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：6( 67-72 )
英文信息